The antibodies are capable of carrying out specific recognition on hepatitis b virus surface antigen, have remarkable enzyme-linked immunosorbent assay (ELSA) with the hepatitis b virus surface antigen and have the neutralizing activity function of resisting hepatitis b virus infection. Furthermore, the antibodies can be used for preparing specific antibody medicines used for preventing and treating liver diseases related to hepatitis b virus, thus being used for clinically preventing and treating the liver diseases caused by the hepatitis b virus.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-102LC | Recombinant Anti-HBsAg Antibody (Fc glycosylation) | ELISA | Mouse antibody |
There are currently no Customer reviews or questions for HPAB-AP360-YC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.